ondansetron has been researched along with guanidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Barann, M; Bönisch, H; Brüss, M; Göthert, M | 1 |
1 review(s) available for ondansetron and guanidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for ondansetron and guanidine
| Article | Year |
|---|---|
Inhibition by steroids of [14C]-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells.
Topics: Animals; Carbon Radioisotopes; Cations; Dexamethasone; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Glucocorticoids; Guanidine; Ion Channels; Lipid Metabolism; Neuroblastoma; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists; Sodium Channels; Solubility; Steroids; Tumor Cells, Cultured; Veratridine | 1999 |